Delta-Fly Pharma,Inc.

4598・Growth Market・Pharmaceuticals

Official website

Delta-Fly Pharma,Inc.

4598・Growth Market・Pharmaceuticals

Official website

Delta-Fly Pharma,Inc.4598

Reference Indicators

Market Cap

16¥100M

P/E (Forecast)

—

P/B

53.2x

Dividend Yield (Forecast)

0.00%

ROE

-5,251.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	300	—	—	—	—
Operating Income	-961	-1,315	-1,403	-1,708	-1,605
Non-operating Income	0	0	0	0	0
Non-operating Expenses	2	9	23	10	19
Ordinary Income	-964	-1,325	-1,426	-1,718	-1,623
Pre-tax Income	-964	-1,325	-1,426	-1,718	-1,623
Income Taxes	3	3	2	2	2
Net Income	-967	-1,328	-1,429	-1,721	-1,625
EBITDA	-959	-1,314	-1,401	-1,706	-1,603
Operating Margin	-320.5%	—	—	—	—
ROA	-73.0%	-146.5%	-97.0%	-396.3%	-659.2%
ROE	-78.5%	-168.4%	-116.0%	-623.9%	-5251.9%